CROSS REFERENCE TO RELATED APPLICATION
This application is a 35 USC .sctn.371 National Phase Entry Application from PCT/EP2005/011252, filed Oct. 19, 2005, and designating the United States.
The present invention relates to novel pharmaceutical formulations containing alkylphosphocholine compounds